GG 705 Pill - pink round, 8mm
Pill with imprint GG 705 is Pink, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Gastric Ulcer Maintenance Treatment; Cutaneous Mastocytosis; Duodenal Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GG 705
Ranitidine Hydrochloride
- Imprint
- GG 705
- Strength
- 150 mg
- Color
- Pink
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients
-
D&C Red No. 30,
hydroxypropyl cellulose,
hypromellose 2910 (3 mPa.s),
magnesium stearate,
microcrystalline cellulose,
peppermint,
sodium starch glycolate type A potato,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00781-1883 (Discontinued) | Sandoz Inc. |
| 51079-0879 (Discontinued) | UDL Laboratories Inc. |
| 66267-0188 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.